|
|
.
See Category: Neoplasms
See Header: Carcinoma in situ of skin of other and unsp parts of face
ICD-10 (CM) Code and Descriptor
|
D04.39 |
Carcinoma in situ of skin of other parts of face
|
D0439 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.27%
|
19.56%
|
8.88%
|
4.35%
|
2.64%
|
1.92%
|
1.68%
|
1.36%
|
1.09%
|
0.67%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D04.39*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
5,753
|
8,340
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,181
|
3,201
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
3,143
|
3,231
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
1,453
|
1,453
|
|
17000
|
DESTRUCT PREMALG LESION |
1,388
|
1,388
|
|
13132
|
CMPLX RPR F/C/C/M/N/AX/G/H/F |
1,141
|
1,141
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
1,089
|
4,373
|
|
17282
|
DSTR MAL LS F/E/E/N/L/M1.1-2 |
1,027
|
1,206
|
|
17312
|
MOHS ADDL STAGE |
1,013
|
1,170
|
|
17281
|
DSTR MAL LS F/E/E/N/L/M .6-1 |
998
|
1,361
|
|
12052
|
INTMD RPR FACE/MM 2.6-5.0 CM |
763
|
763
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
555
|
561
|
|
11103
|
TANGNTL BX SKIN EA SEP/ADDL |
521
|
684
|
|
17280
|
DSTR MAL LS F/E/E/N/L/M .5/< |
512
|
650
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
460
|
651
|
|
17271
|
DSTR MAL LES S/N/H/F/G 0.6-1 |
415
|
621
|
|
17272
|
DSTR MAL LES S/N/H/F/G 1.1-2 |
405
|
522
|
|
17262
|
DSTRJ MAL LES T/A/L 1.1-2.0 |
292
|
371
|
|
11642
|
EXC F/E/E/N/L MAL+MRG 1.1-2 |
279
|
279
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
270
|
311
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D04.39 related to the following DRG Codes:
606-607
|
